These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7716817)

  • 1. [Value of microalbuminuria determination in the non-insulin-dependent diabetic].
    Ben Mami Ben Miled F; Blouza S; Abid A; Ben Hmida L; Ben Rayana MC; Nagati K
    Tunis Med; 1994; 72(8-9):503-7. PubMed ID: 7716817
    [No Abstract]   [Full Text] [Related]  

  • 2. Microalbuminuria in non-insulin-dependent diabetes mellitus. Implications for renal survival.
    Abbott KC; Sanders LR; Bakris GL
    Arch Intern Med; 1994 Jan; 154(2):146-53. PubMed ID: 8285809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Albuminuria in non-insulin-dependent diabetes mellitus. Prevalence, causes, and consequences.
    Gall MA
    Dan Med Bull; 1997 Nov; 44(5):465-85. PubMed ID: 9408734
    [No Abstract]   [Full Text] [Related]  

  • 4. Dyslipidaemia and cardiovascular disease in non-insulin-dependent diabetic patient with and without diabetic nephropathy.
    Parving HH; Gall MA; Nielsen FS
    J Intern Med Suppl; 1994; 736():89-94. PubMed ID: 7986314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is microalbuminuria, an early marker of clinical nephropathy, also a cardiovascular risk factor?].
    Raynaud E; Brun JF; Fédou C; Puech-Cathala AM; Pérez-Martin A; Orsetti A
    Ann Biol Clin (Paris); 1998; 56(6):671-9. PubMed ID: 9853026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microalbuminuria in non-insulin dependent diabetes and essential hypertension--a marker of severe disease.
    Ahmed S
    J Assoc Physicians India; 1995 Jul; 43(7):517-8. PubMed ID: 8713236
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in the diabetic retinopathy epidemiology after 14 years in a population of Type 1 and 2 diabetic patients after the new diabetes mellitus diagnosis criteria and a more strict control of the patients.
    Romero-Aroca P; Fernández-Balart J; Baget-Bernaldiz M; Martinez-Salcedo I; Méndez-Marín I; Salvat-Serra M; Buil-Calvo JA
    J Diabetes Complications; 2009; 23(4):229-38. PubMed ID: 18439844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microalbuminuria in non-insulin dependent diabetes mellitus.
    Patel KL; Mhetras SB; Varthakavi PK; Merchant PC; Nihalani KD
    J Assoc Physicians India; 1999 Jun; 47(6):596-601. PubMed ID: 10999155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of the Dipstick Micraltest II in the screening of microalbuminuria of diabetes mellitus type 2 and essential hypertension.
    Cortés-Sanabria L; Martínez-Ramírez HR; Hernández JL; Rojas-Campos E; Canales-Muñoz JL; Cueto-Manzano AM
    Rev Invest Clin; 2006; 58(3):190-7. PubMed ID: 16958293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Microalbuminuria is an early marker for increased morbidity and mortality].
    Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E
    Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.
    Ravid M; Lang R; Rachmani R; Lishner M
    Arch Intern Med; 1996 Feb; 156(3):286-9. PubMed ID: 8572838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Significant risk factors for development of microalbuminuria and diabetic nephropathy in patients with non-insulin-dependent diabetes].
    Gall ML; Hougaard P; Borch-Johnsen K; Parving HH
    Ugeskr Laeger; 1998 Jul; 160(31):4524-7. PubMed ID: 9700308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of microalbuminuria in type 2 diabetes: lessons learned from the ROADMAP study.
    Ritz E; Menne J; Haller H
    Nephrol Dial Transplant; 2012 Dec; 27 Suppl 4():iv28-30. PubMed ID: 23258807
    [No Abstract]   [Full Text] [Related]  

  • 17. Albuminuria: a target for treatment of type 2 diabetic nephropathy.
    de Zeeuw D
    Semin Nephrol; 2007 Mar; 27(2):172-81. PubMed ID: 17418686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microalbuminuria prevalence study in hypertensive type 2 diabetic patients in Malaysia.
    Kong NC; Chia YC; Khalid BA; Juwita S; Samiah Yasmin AK; Yap LY; Norlaila M; Menon J; Tan C; Fung YK;
    Med J Malaysia; 2006 Oct; 61(4):457-65. PubMed ID: 17243524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microalbuminuria and associated factors in newly diagnosed diabetics.
    Unuigbe EI; Omeife H; Edema T; Ukoli FA
    Niger Postgrad Med J; 2001 Dec; 8(4):187-92. PubMed ID: 11922026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.